Welcome to Elekta’s Capital Markets Day in Stockholm on June 17, 2014
Speakers at this event will be Niklas Savander, Elekta’s President and CEO as of May 1, and other members of Elekta’s management team.
To attend, please register by e-mail to email@example.com no later than June 5, 2014.
It will also be possible to follow the Capital Markets Day over the phone and as a live webcast.
To take part over the phone, please dial in about 5-10 minutes in advance and use the access code: 491152#
- Sweden: +46 8 506 443 86
- UK: +44 20 7153 9154
- US: +1 877 423 0830
We look forward to your participation on June 17.
Director Investor Relations
Director Financial Communication
# # #
For further information, please contact:
Elisabeth Natt och Dag, Information Manager, Elekta AB
+46 733 161 688, firstname.lastname@example.org
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.